history of glp 1 agonists The expanding landscape GLP-1 medicines Another milestone in the evolution
Description
While earlier GLP-1 drugs have decades of data behind them, newer high-potency agonists and multi-agonist combinations will require extended monitoring as their use expands

CMAJ Canadian Med Assoc J 172(9):11991209

GLP-1 receptor agonists are synthetic molecules engineered to mimic the hormone while resisting breakdown, so the signal lasts hours or days instead

Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide

In terms of side effect profile, gastrointestinal disorders are one of the most common reasons for discontinuing treatment with GLP analogs in adolescents[10,11,15,16]

Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: a randomized, controlled clinical trial
